A Seven Immune-Related lncRNAs Model to Increase the Predicted Value of Lung Adenocarcinoma

Jian-Ping Li; Rui Li; Xiao Liu; Chen Huo; Ting-Ting Liu; Jie Yao; Yi-Qing Qu

doi:10.3389/fonc.2020.560779

A Seven Immune-Related lncRNAs Model to Increase the Predicted Value of Lung Adenocarcinoma

Front Oncol. 2020 Oct 14:10:560779. doi: 10.3389/fonc.2020.560779. eCollection 2020.

Authors

Jian-Ping Li¹, Rui Li¹, Xiao Liu¹, Chen Huo¹, Ting-Ting Liu¹, Jie Yao¹, Yi-Qing Qu²

Affiliations

¹ Department of Pulmonary and Critical Care Medicine, Qilu Hospital, Cheeloo College of Medicine, Shandong University, Jinan, China.
² Department of Pulmonary and Critical Care Medicine, Qilu Hospital of Shandong University, Jinan, China.

Abstract

Background: Recent research has shown that immune-related lncRNA plays a crucial part in the tumor immune microenvironment. This study tried to identify immune-related lncRNAs and construct a robust prediction model to increase the predicted value of lung adenocarcinoma (LUAD).

Methods: RNA expression data of LUAD were download from the Cancer Genome Atlas (TCGA) database. Immune genes were acquired from the Molecular Signatures Database (MSigDB). The immune gene related lncRNAs were acquired by the "limma R" package and Cytoscape3.7.1. Cox regression analysis was applied to construct this forecast model. The prognostic model was validated by the testing cohort which was acquired by the bootstrap method.

Results: A total of 551 lncRNA expression profiles including 497 LUAD tissues and 54 non-LUAD tissues were obtained. A total of 331 immune genes were acquired. The result of the Cox regression analysis showed that seven lncRNAs (AC022784-1, NKILA, AC026355-1, AC068338-3, LINC01843, SYNPR-AS1, and AC123595-1) can be performed to construct the prediction model to forecast the prognosis of LUAD. Kaplan-Meier curves indicated that our prediction model can distribute LUAD patients into two different risk groups (high and low) with significant statistical significance (P = 1.484e-07). Cox analysis and independent analysis illustrated that the seven-lncRNAs prediction model was an isolated factor by comparing it with other clinical variables. We validated the accuracy of our model in the testing dataset. Furthermore, the prognostic model also showed higher predictive efficiency than three other published prognostic models. The two different survival groups represented diverse immune features according to principal components analysis. GSEA analysis (gene set enrichment analysis) indicated that seven-lncRNAs signatures may be involved in the progression of tumorigenesis.

Conclusions: We have established a seven immune-related lncRNAs prediction model. This prognostic model had significant clinical significance that increased the predicted value and guided the personalized treatment for LUAD patients.

Keywords: GSEA analysis; immune-related lncRNAs; lung adenocarcinoma; predicted model; prognosis.